All content for Vision to Venture is the property of Enigma and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
AI and biology are transforming drug discovery—but how do they really work together?
In this episode with Arvind Thiagarajan, we dive into the challenges of data scarcity, the impact of regulations, and how computational models are reshaping biotech. Plus, insights on bridging the gap between biochemists and engineers to build better, faster, and more effective drug development processes.
Tune in for a deep tech conversation on the future of medicine!